CeeMCee Pharma Consulting
0525.652.007 · rovalta.com · 26/09/2026
CeeMCee Pharma Consulting
Financial year 2025 · Closed on 31/12/2025
Overview
Identity
Source · BCE/KBOCeeMCee Pharma Consulting is a Private limited company incorporated in 2013. Its main activity is: Research and experimental development on natural sciences and engineering. Its registered office is in Zoersel.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0525.652.007
- Incorporation
- 02/04/2013
- Legal form
- Private limited company
- Registered office
- Amazonelaan 26
2980 Zoersel · FlandreSee on map - Contributed capital
- 18 600,00 €
- Latest accounts
- 31/12/2025
Financials
Source · NBB, 12 filingsTrend over 5 financial years
| 2025 | 2024 | 2023 | 2022 | 2021 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | 94,9 k € | -2.9% | 97,8 k € | +48.9% | 65,7 k € | -40.1% | 109,6 k € | +48.4% | 73,8 k € |
| EBITDA | 93,2 k € | -4.2% | 97,3 k € | +50.7% | 64,6 k € | -40.6% | 108,7 k € | +48.9% | 73 k € |
| Operating result | 86,5 k € | -1.2% | 87,6 k € | +55.2% | 56,4 k € | -44.0% | 100,7 k € | +54.1% | 65,4 k € |
| Net result | 62,4 k € | -3.3% | 64,5 k € | +48.2% | 43,5 k € | -39.4% | 71,9 k € | +48.4% | 48,4 k € |
| Balance sheet | |||||||||
| Equity | 238 k € | +21.0% | 196,6 k € | +29.3% | 152,1 k € | +6.5% | 142,8 k € | +90.2% | 75,1 k € |
| Total assets | 281,8 k € | +23.3% | 228,6 k € | +18.3% | 193,2 k € | +16.1% | 166,3 k € | +54.3% | 107,8 k € |
| Cash | 211,4 k € | +31.6% | 160,7 k € | +16.2% | 138,3 k € | +25.1% | 110,6 k € | +86.6% | 59,3 k € |
| Debts | 43,8 k € | +37.0% | 32 k € | -12.6% | 36,6 k € | +55.6% | 23,5 k € | -20.0% | 29,4 k € |
Valuation
Indicative valuation
As an indication, this company is worth
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Financials
Full financial information
Source · NBB| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/01/2025 | 01/01/2024 | 01/01/2023 | 01/01/2022 | 01/01/2021 | 01/01/2020 |
| Closing of the financial year | 31/12/2025 | 31/12/2024 | 31/12/2023 | 31/12/2022 | 31/12/2021 | 31/12/2020 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 21/05/2026 | 31/07/2025 | 06/05/2024 | 23/06/2023 | 14/04/2022 | 07/06/2021 |
| General meeting | 21/04/2026 | 30/06/2025 | 26/04/2024 | 26/05/2023 | 01/04/2022 | 02/04/2021 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for freeAnnual accounts filings
Source · NBB, 12 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 31/12/2025 | 21/04/2026 | 21/05/2026 | Dutch | |
| Micro model | 31/12/2024 | 30/06/2025 | 31/07/2025 | Dutch | |
| Micro model | 31/12/2023 | 26/04/2024 | 06/05/2024 | Dutch | |
| Micro model | 31/12/2022 | 26/05/2023 | 23/06/2023 | Dutch | |
| Micro model | 31/12/2021 | 01/04/2022 | 14/04/2022 | Dutch | |
| Micro model | 31/12/2020 | 02/04/2021 | 07/06/2021 | Dutch | |
| Micro model | 31/12/2019 | 03/04/2020 | 05/05/2020 | Dutch | |
| Micro model | 31/12/2018 | 05/04/2019 | 14/05/2019 | Dutch | |
| Micro model | 31/12/2017 | 06/04/2018 | 09/07/2018 | Dutch | |
| Micro model | 31/12/2016 | 07/04/2017 | 03/07/2017 | Dutch | |
| Abridged model | 31/12/2015 | 01/04/2016 | 02/06/2016 | Dutch | |
| Abridged model | 31/12/2014 | 03/04/2015 | 09/04/2015 | Dutch |
Valuation
Indicative valuation
As an indication, this company is worth
between 500 k€ and 1 M€
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 31/12/20251 active · 1 ended
Active mandates
Ended mandates
Ownership and network
Looking for more information about this company?
Try for freePublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2025Annual accounts 202562,4 k €↓
- 2024Annual accounts 202464,5 k €↑
- 2023Annual accounts 202343,5 k €↓
- 2022Annual accounts 202271,9 k €↑
- 2021Annual accounts 202148,4 k €
- 02/04/2013IncorporationPrivate limited company